Cost Effectiveness and Resource Allocation

Table 3 Prevalence of HBsAg and HCV by country.

From: Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an economic evaluation

			TTI prevalence
Country	Reference	Year	HBsAg	Anti HCv
Botswana	[2]	2004	0.05	NA
South Africa	[2]	2004	0.05	NA
Kenya	[2]	2004	0.042	NA
	[39]	1999	0.039	0.018
Tanzania	[40]	2006	0.048	NA
	[41]	2006	0.088	0.015
	[42]	2007	0.053	0.055

NA: not available

Back to article page

ISSN: 1478-7547

Contact us

General enquiries: journalsubmissions@springernature.com